Cleerly
PrivateLast Round
Series C
Extension
Dec 4, 2024
Total Funding Raised
$383M
Company Overview
Cleerly operates in Healthcare & Life Sciences and is based in Denver, Colorado. Its latest recorded funding round was a Series C Extension round in December 2024.
Cleerly is a healthcare technology company that offers an AI-driven platform for quantifying and characterizing plaque buildup in coronary arteries to enhance the identification and treatment of at-risk patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Computer Vision
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cleerly Comparables
Compare Cleerly with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Elucid | 88% | |
| HeartFlow | 82% | |
| Artrya Ltd | 81% |
For institutional investors. Book with your work email.
Cleerly Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Dec 4, 2024 | ||||
| Series C | Jul 25, 2022 | ||||
| Series B | Jun 21, 2021 | ||||
| Series A | Apr 3, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cleerly Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breyer Capital | Series C |
| DigiTx Partners | Series B, Series C |
| New Leaf Venture Partners | Series B, Series C |
| Heartland Healthcare Capital | Series C |
| Catalytic Impact Foundation | Series C |
| Cigna Ventures | Series B, Series C |
| Fidelity Management & Research Company | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 14, 2026
Accused of infringing on six patents related to AI diagnostic tools.
- Mar 25, 2026
Launched Cleerly PREVIEW for CAD imaging case prioritization.
For institutional investors. Book with your work email.
Cleerly Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cleerly's valuation, stock price, and market status.
Is Cleerly a public or private company?
Cleerly is a private company.
What is the current stock price of Cleerly?
Cleerly is a private company, so its shares have no public market price. Caplight tracks Cleerly's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cleerly worth (valuation)?
Valuation information for Cleerly is not publicly available.
Can I buy Cleerly stock?
Cleerly shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cleerly's last funding round?
Cleerly's most recent funding round was Series C Extension on December 4, 2024.
Who are the main investors in Cleerly?
Key investors in Cleerly include Fidelity Management & Research Company, Vensana Capital, T. Rowe Price, Insight Partners.
Will Cleerly IPO soon?
No public IPO plans have been announced for Cleerly.
How can I track Cleerly secondary market activity?
Caplight tracks bids, offers, and trades in Cleerly's shares on secondary markets.